Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial

NCT00643968 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: EFV+TDF
DRUG: EFV+3TC+TDF

Sponsor

Gilead Sciences